Most Recent
Novartis wins injunction to stop generic version of blockbuster MS drug, for now
Intellectual Property 2021-04-12 2:51 pm By Cindy Cameronne

Swiss drug giant Novartis has secured an injunction temporarily blocking drug maker Pharmacor from launching a generic version of the company’s top-selling MS drug Gilenya in Australia.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Patent attorneys who jumped ship hit back in Pizzeys client poaching lawsuit
Intellectual Property 2021-02-24 9:49 pm By Spencer Fowler Steen

Two patent attorneys being sued by boutique IP firm Pizzeys Patent and Trade Mark Attorneys have hit back against claims they misused confidential information to poach clients, arguing the terms of the non-compete restraint in their employment contracts were “unclear”, “unreasonable” and “unenforceable”.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Patent attorneys lured lucrative US law firm clients from IP boutique, new suit claims
Intellectual Property 2020-12-16 2:38 pm By Christine Caulfield

Two patent attorneys who resigned from Pizzeys Patent and Trade Mark Attorneys to launch a competing business performed work for clients of the boutique IP firm a year after they jumped ship, in breach of their employment contracts, a lawsuit claims.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Sydney Opera House fights China group’s trade mark
Intellectual Property 2020-12-04 12:45 pm By Miklos Bolza

The Sydney Opera House is challenging a ruling that denied its opposition to a trade mark application filed by a China-Australia trade association that featured an image of the opera house sails together with the Great Wall of China.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Mylan fails in High Court bid to save patents for top seller Lipidil
Intellectual Property 2020-11-06 12:06 pm By Cat Fredenburgh

The High Court has declined to take up Mylan’s challenge to a Full Court ruling upholding the invalidity of three patents for its blockbuster cholesterol drug Lipidil.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Nthalmic directors accused of misusing confidential information in lens patent applications
Intellectual Property 2020-09-15 6:10 pm By Miklos Bolza

Sydney-based research foundation Brien Holden Vision Institute has filed a lawsuit alleging three senior researchers misused confidential information when they jumped ship to a rival research group and filed applications to patent seven inventions for opthalmic lenses designed to treat myopia allegedly based on that information.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Hanwha can amend solar patent at centre of IP feud with rivals
Intellectual Property 2020-08-31 4:48 pm By Christine Caulfield

The Federal Court has granted a bid by global solar cell manufacturer Hanwha to amend the patent behind its solar technology at the centre of a hotly contested infringement case against three rivals.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Procter & Gamble drops spat with Colgate-Palmolive over whitening toothpaste ads
Competition & Consumer Protection 2020-08-17 1:32 pm By Christine Caulfield

Consumer goods giant Procter & Gamble has dropped a lawsuit accusing competitor Colgate-Palmolive of breaching consumer laws by making false claims about the performance of its whitening toothpaste that threatened to push its own brand of whitener off the shelves.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Wicked Sister dessert maker suffers loss in trade mark battle
Intellectual Property 2020-08-10 5:54 pm By Miklos Bolza

The company that makes Wicked Sister desserts has suffered a defeat in its trade mark battle against the maker of Wicked dipping sauces, with a judge removing some of its trade marks from the register.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?

Hytera can’t ‘repackage’ deputy director as lay witness to avoid evidence rules on relevance
Intellectual Property 2020-08-06 3:39 pm By Miklos Bolza

A judge has found that Hytera Communications cannot “repackage” evidence given by one of its deputy directors to avoid rules about opinion evidence while defending a copyright infringement case by Motorola Solutions.

Subscribe to Lawyerly to access this article.

Already a subscriber?

Lost your password?